Annual Working Capital
$110.25 M
-$103.51 M-48.42%
December 31, 2024
Summary
- As of March 13, 2025, PRLD annual working capital is $110.25 million, with the most recent change of -$103.51 million (-48.42%) on December 31, 2024.
- During the last 3 years, PRLD annual working capital has fallen by -$165.66 million (-60.04%).
- PRLD annual working capital is now -60.04% below its all-time high of $275.91 million, reached on December 31, 2021.
Performance
PRLD Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$110.25 M
-$23.91 M-17.82%
December 31, 2024
Summary
- As of March 13, 2025, PRLD quarterly working capital is $110.25 million, with the most recent change of -$23.91 million (-17.82%) on December 31, 2024.
- Over the past year, PRLD quarterly working capital has dropped by -$23.91 million (-17.82%).
- PRLD quarterly working capital is now -68.73% below its all-time high of $352.59 million, reached on March 31, 2021.
Performance
PRLD Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
PRLD Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.4% | -17.8% |
| 3 y3 years | -60.0% | -39.6% |
| 5 y5 years | +616.5% | -39.6% |
PRLD Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.0% | at low | -60.0% | at low |
| 5 y | 5-year | -60.0% | +616.5% | -68.7% | +616.5% |
| alltime | all time | -60.0% | +738.6% | -68.7% | +616.5% |
Prelude Therapeutics Incorporated Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $110.25 M(-48.4%) | $110.25 M(-17.8%) |
| Sep 2024 | - | $134.16 M(-15.8%) |
| Jun 2024 | - | $159.38 M(-15.1%) |
| Mar 2024 | - | $187.72 M(-12.2%) |
| Dec 2023 | $213.76 M(+17.0%) | $213.76 M(-2.0%) |
| Sep 2023 | - | $218.02 M(-11.0%) |
| Jun 2023 | - | $245.02 M(+57.5%) |
| Mar 2023 | - | $155.60 M(-14.8%) |
| Dec 2022 | $182.68 M | $182.68 M(-11.0%) |
| Sep 2022 | - | $205.33 M(-11.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $232.81 M(-8.3%) |
| Mar 2022 | - | $253.90 M(-8.0%) |
| Dec 2021 | $275.91 M(+31.7%) | $275.91 M(-9.9%) |
| Sep 2021 | - | $306.23 M(-7.2%) |
| Jun 2021 | - | $329.90 M(-6.4%) |
| Mar 2021 | - | $352.59 M(+68.4%) |
| Dec 2020 | $209.43 M(+1260.9%) | $209.43 M(-7.6%) |
| Sep 2020 | - | $226.70 M(+804.7%) |
| Jun 2020 | - | $25.06 M(+62.8%) |
| Dec 2019 | $15.39 M(+17.0%) | $15.39 M |
| Dec 2018 | $13.15 M | - |
FAQ
- What is Prelude Therapeutics Incorporated annual working capital?
- What is the all time high annual working capital for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual working capital year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly working capital?
- What is the all time high quarterly working capital for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly working capital year-on-year change?
What is Prelude Therapeutics Incorporated annual working capital?
The current annual working capital of PRLD is $110.25 M
What is the all time high annual working capital for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual working capital is $275.91 M
What is Prelude Therapeutics Incorporated annual working capital year-on-year change?
Over the past year, PRLD annual working capital has changed by -$103.51 M (-48.42%)
What is Prelude Therapeutics Incorporated quarterly working capital?
The current quarterly working capital of PRLD is $110.25 M
What is the all time high quarterly working capital for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly working capital is $352.59 M
What is Prelude Therapeutics Incorporated quarterly working capital year-on-year change?
Over the past year, PRLD quarterly working capital has changed by -$23.91 M (-17.82%)